Aaryan Mehta

A large custom synthesis player in the latest earnings call commented about signing long -term contracts with 2 customers for iodine -based contrast media. So, commercialization for one has already started and they might even enter gadolinium. So, should we consider this as a tailwind considering that we can sell them KSMs or intermediates or are they backward integrated enough so this could be a headwind for us.

Divis recently mentioned this in their earnings call that they have signed long-term contracts?

Okay. So, can this be a tailwind for us considering they can be a potential customer? Or do you see this as competition?